The final, formatted version of the article will be published soon.
ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Clinical Infectious Diseases
Volume 14 - 2024 |
doi: 10.3389/fcimb.2024.1464485
This article is part of the Research Topic Current molecular, immunological, pathological and clinical aspects of pathogenic infections View all articles
A Simple Predictive Model for Puerperal Infections: Emphasizing Risk Factors and Pathogen Analysis
Provisionally accepted- 1 Chongqing Health Center for Women and Children, Chongqing, Chongqing, China
- 2 Department of Obstetrics and Gynecology, Women and Children's Hospital of Chongqing Medical University, Chongqing, China
- 3 Guizhou Provincial People's Hospital, Guiyang, Guizhou Province, China
- 4 Center for Reproductive Medicine, Chongqing Health Center for Women and Children, Women and Children's Hospital of Chongqing Medical University, Chongqing, China
Background: Puerperal infection (PI) accounting for approximately 11% of maternal deaths globally is an important preventable cause of maternal morbidity and mortality. This study aims to analyze the high-risk factors and pathogenic bacteria of PI, design a nomogram to predict the risk of PI occurrence, and provide clinical guidance for prevention and treatment to improve maternal outcomes.Methods:A total of 525 pregnant women were included in the study. The mothers were randomly divided into a training cohort (n=367) and a test cohort (n=158). The performance of our model was assessed using the area under the receiver operating characteristic (ROC) curve, calibration curve, and decision curve analyses.All the women in the group of PI underwent blood culture tests, if the bacteria were detected, drug sensitivity tests were performed. The drug sensitivity spectrum was recorded and analyzed.Results: Univariate analysis showed that 12 indicators were significantly different (P < 0.05). Logistic regression analysis showed 6 factors, such as parity, number of vaginal examinations, amount of postpartum bleeding, antibiotics administeredtted in one week before admission, induced labor, and indwelling catheter were significantly different between the PI group and control group (P < 0.05). The area under the ROC curve was 0.904 (95% CI: 0.871-0.936) in the training set and 0.890 (95% CI: 0.837-0.942) in the test set. The calibration curve of the nomogram showed good agreement between prediction and observation. The analysis of the clinical decision curve showed that the nomogram is of practical significance. There were 100 patients with positive blood cultures in the puerperal infectionPI group, and EscherichiaE.coli was the main pathogenic bacteria, accounting for 89%. The sensitivity to Meropenem and Imipenem was 100%, to Piperacillin tazobactam 97.75%, to Ceftazidime 95.51%, and to Amoxicillin/Clavulanat (AMC) was 93.26%.The risk of PI will be significantly reduced by controlling the number of vaginal examinations less than 4 times, postpartum hemorrhage less than 4 times, postpartum hemorrhage less than 414ml, and reducing the time of urethral catheter indwelling. If PI was clinically diagnosed or highly suspected, it was recommended to use antibiotics that were sensitive to EscherichiaE. coli, such as Piperacillin tazobactam, Ceftazidime, and AMC.
Keywords: WBC, white blood cell, N%, neutrophilic granulocyte percentage, HGB, hemoglobin, GDM, gestational diabetes, GBS, Group B streptococci, ICP, Intrahepatic cholestasis of pregnancy, BMI, body mass index, PROM, premature rupture of membranes
Received: 13 Oct 2024; Accepted: 25 Nov 2024.
Copyright: © 2024 Wen, Ming, Yang and Qi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Hongbo Qi, Center for Reproductive Medicine, Chongqing Health Center for Women and Children, Women and Children's Hospital of Chongqing Medical University, Chongqing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.